Main content

Towards the Synthesis of Novel PARP Inhibitors through Diels-Alder Chemistry

Show simple item record

dc.contributor.advisor Schwan, Adrian L. Nikoloska, Irena 2012-05-04T16:59:44Z 2012-05-04T16:59:44Z 2012-04 2012-04-30 2012-05-04
dc.description.abstract Poly(ADP-ribose) polymerase (PARP) represents a large family of enzymes that are activated upon DNA breakage, which are then involved in a cascade of reactions that eventually lead to cell death. PARPs, known to cause a variety of damage to the human body, are targets of many researches’ investigating potential inhibition mechanisms. To this point, plenty of PARP inhibitors have been synthesized and tested for potency against many diseases. Some have great potency against particular diseases, while others are already being used as drugs. The current research suggests a potential synthesis of novel PARP inhibitors, to be accomplished through Diels-Alder chemistry. The proposed compounds consist of an isoindolinone core bearing different functional groups. Three different strategies are described for the synthesis of the novel PARP inhibitors and all protocols involve sulfur dioxide extrusion chemistry to create a diene, the desired transient starting material. The diene is envisioned further to be reacted with a variety of dienophiles to give possibly potential PARP inhibitors. en_US
dc.description.sponsorship NSERC en_US
dc.language.iso en en_US
dc.rights.uri *
dc.subject PARP en_US
dc.subject Diels-Alder en_US
dc.subject isoindolinone en_US
dc.title Towards the Synthesis of Novel PARP Inhibitors through Diels-Alder Chemistry en_US
dc.type Thesis en_US Chemistry en_US Master of Science en_US Department of Chemistry en_US
dc.rights.license All items in the Atrium are protected by copyright with all rights reserved unless otherwise indicated.

Files in this item

Files Size Format View Description
THESIS_-_Irena_Nikoloska.pdf 2.019Mb PDF View/Open Nikoloska

This item appears in the following Collection(s)

Show simple item record Except where otherwise noted, this item's license is described as